Your browser doesn't support javascript.
loading
Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study.
Barratt, Daniel T; Bandak, Benedikte; Klepstad, Pål; Dale, Ola; Kaasa, Stein; Christrup, Lona L; Tuke, Jonathan; Somogyi, Andrew A.
Afiliação
  • Barratt DT; aDiscipline of Pharmacology, School of Medical Sciences bSchool of Mathematical Sciences, University of Adelaide cDepartment of Clinical Pharmacology, Royal Adelaide Hospital, Adelaide, Australia dDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark eDepartment of Circulation and Medical Imaging, Norwegian University of Science and Technology fDepartment of Cancer Research and Molecular Medicine, European Palliative Care Research Centre, Trondheim, Norway.
Pharmacogenet Genomics ; 24(4): 185-94, 2014 Apr.
Article em En | MEDLINE | ID: mdl-24469018

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dor / Fentanila / Citocromo P-450 CYP3A / Analgésicos Opioides / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacogenet Genomics Assunto da revista: FARMACOLOGIA / GENETICA MEDICA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dor / Fentanila / Citocromo P-450 CYP3A / Analgésicos Opioides / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacogenet Genomics Assunto da revista: FARMACOLOGIA / GENETICA MEDICA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Noruega